Latest Prescription Drugs news
Dual-Targeted Therapies Plus Chemo Improve Objective Response Rate in BRAF V600E Metastatic CRC
posted February 4th
by modernClinician Editorial Team
by modernClinician Editorial Team
FDA Approval Expands Earlier Use of Enhertu for Metastatic Breast Cancer
posted February 3rd
by modernClinician Editorial Team
by modernClinician Editorial Team
FDA Approves Datroway for HR-Positive, HER2-Negative Breast Cancer
posted January 31st
by modernClinician Editorial Team
by modernClinician Editorial Team
.jpg)
Distribution of Opioid Meds Lower in Majority Non-White Communities
posted January 31st
by modernClinician Editorial Team
by modernClinician Editorial Team
Study IDs Risk Factors for Ketoacidosis in Adults With T2D Receiving SGLT2 Inhibitors 
Anifrolumab Tied to Lower Hospitalization, Infection Risk in Lupus .jpg)
Recommendations Updated for Management of Anemia in CKD 
Therapies Compared for Newly Diagnosed Multiple Sclerosis Related Articles
Initial Rx Length Tied to Long-Term Use of Z-Drugs 
Azacitidine + Venetoclax Tied to Improved Event-Free Survival in Adults With AML 
Updated Recommendations Address Medications to Prevent Migraine in Adults 
Paternal Exposure to Valproate Not Linked to Offspring Neurodevelopmental Disorders Monthly Specialist Briefings
Stay Connected
